FDA Finds Weak Process Controls at Anesthesia Associates

June 24, 2019

A March 11-14 inspection of Anesthesia Associates’ San Marcos, California facility by the FDA revealed inadequate process controls.

The company manufactures and distributes reusable products for anesthesia and respiratory care, including the Jet Ventilator, a Class II life-sustaining device.

The inspection revealed that medical device reporting procedures were not maintained. The company’s medical device flow charts, which the president identified as the firm’s MDR procedures, didn't include requirements for submitting MDR reports or recordkeeping.

Medical Devices Inspections and Audits

FDA Provides Update on Haimen Shengbang Laboratory’s Recall of Its Viral Transport Media Containers

FDA Finds Weak Process Controls at Anesthesia Associates

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

1st Annual Quality Management vSummit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

MicroPort Navibot Receives 510(k) Clearance for Its SkyWalker System

FDA Expands Approval of Pfizer and Myovant’s Myfembree to Include Endometriosis

FDA Provides Update on Haimen Shengbang Laboratory’s Recall of Its Viral Transport Media Containers

FDA Issues EUA for Monkeypox Vaccine

The Revised ICH E8: A Guide to New Clinical Trial Requirements